Samsung Biologics
207940.KS
#432
Rank
NZ$81.34 B
Marketcap
$1,143
Share price
-0.42%
Change (1 day)
29.69%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): NZ$1.99 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are NZ$3.27 Billion. In 2023 the company made an earning of NZ$1.56 Billion, an increase over its 2022 earnings that were of NZ$1.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$1.99 B27.5%
2023 NZ$1.56 B9.77%
2022 NZ$1.42 B67.66%
2021 NZ$0.85 B103.97%
2020 NZ$0.41 B57.39%
2019 NZ$0.26 B-45.46%
2018 NZ$0.48 B-390%
2017 -NZ$0.17 Billion-46.74%
2016 -NZ$0.32 Billion